221 related articles for article (PubMed ID: 2696727)
1. Differences in the phenotypes of cells mediating anti-tumour immunity at various stages of tumour progression in mice.
Dent LA; Spencer LK; Attridge S; Finlay-Jones JJ
Immunol Cell Biol; 1989 Dec; 67 ( Pt 6)():403-12. PubMed ID: 2696727
[TBL] [Abstract][Full Text] [Related]
2. Mediation of in vivo tumor-neutralizing activity by Lyt-2+ as well as L3T4+ T cell subsets.
Yoshioka T; Sato S; Ogata M; Sakamoto K; Sano H; Shima J; Yamamoto H; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1988 Jan; 79(1):91-8. PubMed ID: 2965692
[TBL] [Abstract][Full Text] [Related]
3. In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas.
Dent LA; Finlay-Jones JJ
Br J Cancer; 1985 Apr; 51(4):533-41. PubMed ID: 3156616
[TBL] [Abstract][Full Text] [Related]
4. CD4-/CD8-T cells: amplification in spleens of mice following in vivo treatment with monoclonal antibody anti-L3T4.
Ermak TH; Steger HJ
Eur J Immunol; 1988 Feb; 18(2):231-5. PubMed ID: 2894995
[TBL] [Abstract][Full Text] [Related]
5. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
Barker E; Mokyr MB
Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
[TBL] [Abstract][Full Text] [Related]
6. Selective suppression of the generation of anti-tumor L3T4+ but not of Lyt-2+ T cell-mediated immunity in the tumor-bearing state.
Sano H; Sato S; Shima J; Tada T; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1988 Jul; 79(7):857-65. PubMed ID: 3139599
[TBL] [Abstract][Full Text] [Related]
7. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
Fuyama S; Komatsu H; Arai S
Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
[TBL] [Abstract][Full Text] [Related]
8. Ly-6C+ natural T (NT) cells mediate immune surveillance against NK-sensitive and NK-resistant transplantable tumours in certain strains of mice.
Martiniello R; Burton RC; Smart YC
Int J Cancer; 1996 May; 66(4):532-7. PubMed ID: 8635870
[TBL] [Abstract][Full Text] [Related]
9. Development of autoreactive L3T4+ T cells from double-negative (L3T4-/Ly-2-) Thy-1+ spleen cells of normal mice.
Reimann J; Bellan A; Conradt P
Eur J Immunol; 1988 Jul; 18(7):989-99. PubMed ID: 2900151
[TBL] [Abstract][Full Text] [Related]
10. Resistance to cutaneous leishmaniasis in nude mice injected with L3T4+ T cells but not with Ly-2+ T cells.
Moll H; Scollay R; Mitchell GF
Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():57-63. PubMed ID: 3259538
[TBL] [Abstract][Full Text] [Related]
11. Modulation and biological effects of Ly-6.2 expression on EL4 tumour cells.
Matossian-Rogers A; Rogers PD
Br J Cancer; 1987 Dec; 56(6):738-43. PubMed ID: 3501729
[TBL] [Abstract][Full Text] [Related]
12. Selective production of interleukin 3 (IL3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro by murine L3T4+ T cells: lack of spontaneous IL3 and GM-CSF production by Ly-2-/L3T4- lpr subset.
Davignon JL; Kimoto M; Kindler V; De Kossodo S; Vassalli P; Izui S
Eur J Immunol; 1988 Sep; 18(9):1367-72. PubMed ID: 3139430
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression of graft rejection with idarubicin-monoclonal antibody conjugates by elimination of T cell subsets in vivo.
Smyth MJ; Pietersz GA; McKenzie IF
Transplantation; 1988 Jul; 46(1):126-31. PubMed ID: 2899362
[TBL] [Abstract][Full Text] [Related]
14. Identification of early stages of T lymphocyte development in the thymus cortex and medulla.
Scollay R; Shortman K
J Immunol; 1985 Jun; 134(6):3632-42. PubMed ID: 3886788
[TBL] [Abstract][Full Text] [Related]
15. Origin of autoreactive T helper cells. I. Characterization of Thy-1+, Lyt-, L3T4- precursors in the spleen of normal mice.
de Talance A; Regnier D; Spinella S; Morisset J; Seman M
J Immunol; 1986 Aug; 137(4):1101-8. PubMed ID: 2426351
[TBL] [Abstract][Full Text] [Related]
16. Proliferation of Ly-1 B cells in autoimmune NZB and (NZB x NZW)F1 mice.
Wofsy D; Chiang NY
Eur J Immunol; 1987 Jun; 17(6):809-14. PubMed ID: 2954827
[TBL] [Abstract][Full Text] [Related]
17. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
Moll H; Scollay R
Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
[TBL] [Abstract][Full Text] [Related]
18. Antilymphocytic antibodies and bone marrow transplantation. XI. Evidence that reduced Thy-1 expression in Thy-1.1 mice prevents suppression of graft-versus-host disease with anti-Thy-1 monoclonal antibodies.
Mysliwietz J; Thierfelder S; Hoffmann-Fezer G; Kummer U
Transplantation; 1990 Apr; 49(4):749-55. PubMed ID: 1970200
[TBL] [Abstract][Full Text] [Related]
19. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.
North RJ; Bursuker I
J Exp Med; 1984 May; 159(5):1295-311. PubMed ID: 6232335
[TBL] [Abstract][Full Text] [Related]
20. The adoptive transfer of T-cell dependent immunity to Plasmodium chabaudi chabaudi in CBA/Ca mice is achieved only after superinfection of immune spleen cell donors.
Favila-Castillo L; Jarra W; Brown KN
Parasite Immunol; 1990 May; 12(3):297-307. PubMed ID: 2143571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
